Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tissue Regenix (GB:TRX)
:TRX
Holding GB:TRX?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 19, 2024 | Kirsten Lund Finance Director | xxxxxxxxxxxxx | £37058 |
| Jun 19, 2024 | David Claiborne Cocke Chief Financial Officer | xxxxxxxxxxxxx | £38556 |
| Jun 19, 2024 | Daniel Lee Chief Executive Officer | xxxxxxxxxxxxx | £53443 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Tissue Regenix (GB:TRX)?
Currently, no data Available
What percentage of Tissue Regenix (GB:TRX) stock is held by institutional investors?
Currently, no data Available
What percentage of Tissue Regenix (GB:TRX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Tissue Regenix (GB:TRX)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.